Musaffa Logo
Zhejiang Wecome Pharmaceutical Co Ltd 300878.SZ

Last Updated: Jul 16, 12:00 AM·SZSE

Zhejiang Wecome Pharmaceutical Co Ltd

Zhejiang Wecome Pharmaceutical Co Ltd. Stock Analysis 300878.SZ

China Health Care Small Cap
Zhejiang Wecome Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of modern Chinese and western medicines. The company is headquartered in Lishui, Zhejiang. The company went IPO on 2020-08-24. The firm's main products include Chinese patent medicines such as Yinhuang drop pills, Yimucao soft capsules, Yimucao dispersible tablets, Qiye Shen'an dispersible tablets, Fengliao Changweikang dispersible tablets, and Ginseng Jianpi tablets, as well as Western medicines such as roxithromycin soft capsules. The production dosage forms cover hard capsules, tablets, granules, soft capsules, and pills (drop pills). The firm is also engaged in the distribution business such as retail chains of pharmaceutical commercial products. The firm mainly operates its businesses in the domestic market.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!